Bruker Corporation today announced the launch of the Beacon Discovery ™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop ...
Building on Bruker’s proprietary Opto-Electrical Positioning (OEP) technology and scalable OptoSelect™ microfluidic chips, Beacon Discovery complements the floor-standing premium Beacon® platforms.
From stable transfection to bioreactor scale-up, cell line development is a complex and resource-intensive process. Researchers face challenges in achieving monoclonality, optimizing media, managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results